Psychiatry · Southfield, MI
NPI
1497796379
Since 2006
Specialty
Psychiatry
Code 2084P0800X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
22170 W 9 Mile Rd
Southfield, MI, 48033
Phone (248) 372-6800
Groups this clinician bills Medicare through
Medicare paid, 2024
$22K
474 services
Medicare patients, 2024
60
Average age 53
Drug cost, 2024
$1.2M
3,817 prescriptions
Company payments, 2025
$1,682
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Sung-Ran Cho was code 90833 (psychotherapy - nongroup), 169 times for 50 patients. In total Sung-Ran Cho billed 474 services in 6 codes, and Medicare paid $22K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-08-01.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 90833 Psychotherapy - Nongroup | Office | 169 | 50 | $46.74 | $7,899 |
| 99214 Office E&M - Established | Office | 161 | 48 | $71.94 | $12K |
| 90785 Behavioral Health Services | Office | 78 | 29 | $9.83 | $767 |
| 96372 Injection Administration | Office | 52 | 18 | $9.36 | $486 |
By year: 2022 $29K for 475 services; 2023 $24K for 465 services; 2024 $22K for 474 services.
Medicare prescription drug claims, 2024
In 2024, the drug Sung-Ran Cho prescribed most often to Medicare patients was Benztropine Mesylate, with 363 prescriptions and refills. In total Sung-Ran Cho wrote 3,817 Medicare prescriptions that cost $1.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Benztropine Mesylate Generic | 363 | 364 | 39 | $4,480 |
| Quetiapine Fumarate Generic | 272 | 279 | 23 | $3,386 |
| Olanzapine Generic | 222 | 225 | 21 | $3,645 |
| Fluphenazine Hcl Generic | 219 | 219 | 22 | $31K |
| Divalproex Sodium Er Divalproex Sodium | 216 | 219 | 21 | $12K |
| Trazodone Hcl Generic | 193 | 202 | 27 | $3,099 |
| Clozapine Generic | 162 | 163 | 14 | $17K |
| Sertraline Hcl Generic | 157 | 166 | 22 | $1,255 |
| Invega Sustenna Paliperidone Palmitate | 132 | 132 | 19 | $418K |
| Lamotrigine Generic | 127 | 133 | 14 | $924 |
| Buspirone Hcl Generic | 111 | 119 | 14 | $1,671 |
| Aripiprazole Generic | 102 | 106 | 11 | $8,917 |
| Risperidone Generic | 92 | 98 | 11 | $819 |
| Divalproex Sodium Generic | 87 | 94 | Under 11 | $1,602 |
| Clonazepam Generic | 75 | 75 | 12 | $368 |
Brand drugs: 428 claims; generic drugs: 3,389 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Sung-Ran Cho $1,682 ($1,682 in general payments such as food, travel and fees) from 10 companies. The largest payer was E.R. Squibb & Sons, L.L.C. with $391.
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. BMY | 21 | $391 |
| Teva Pharmaceuticals USA, Inc. TEVA | 12 | $262 |
| Alkermes, Inc. ALKS | 11 | $218 |
| Abbvie Inc. ABBV | 9 | $208 |
| Indivior Inc. INDV | 8 | $198 |
| Neurocrine BioSciences, Inc. NBIX | 13 | $193 |
| Janssen Pharmaceuticals, Inc JNJ | 4 | $89.5 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 3 | $74 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 2 | $31.01 |
| Vanda Pharmaceuticals Inc. VNDA | 1 | $16.02 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.